Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • Country/Region
    • Clinic Portal
      • +0034963905310
    • Request Information
    • +34 96 390 53 10
    • Part of brands: |
    InternationalInternational
    • Country/Region
      • Part of brands: |
      • We guide you
        • Fertility
          • What to do if…
        • Prevent Inherited Diseases
          • Carrier Genetic Test
        • Worry-free Pregnancy
          • NACE
          • Prenatal Diagnostics
          • Newborn Health
      • Reproductive Health
        • Specialists
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • POC
          • SAT
          • Newborn Screening
        • Patients
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • SAT
          • POC
      • Diagnostics
      • About us
        • Igenomix Research
        • About Igenomix
        • Igenomix Worldwide
      • Academy
      • Blog
      Genomics Precision Diagnostic > Rare Disease Precision Panel > Prader Willi/Angelman Syndrome Precision Panel

      Prader Willi/Angelman Syndrome Precision Panel

      Prader Willi and Angelman Syndrome are neurodevelopmental disorders caused by a deletion of a region in chromosome 15 and are classically known as genomic imprinting disorders. These disorders are characterized by an imprinting center controlling the expression of selected genes in chromosome 15, therefore a deletion in these areas affect the expression of certain genes.
      Overview
      Indication
      Clinical Utility
      Genes & Diseases
      Methodology
      References

      Overview

      • Prader Willi and Angelman Syndrome are neurodevelopmental disorders caused by a deletion of a region in chromosome 15 and are classically known as genomic imprinting disorders. These disorders are characterized by an imprinting center controlling the expression of selected genes in chromosome 15, therefore a deletion in these areas affect the expression of certain genes. Depending on the deletion occurring in the maternal or paternal chromosome the resulting disorder is Prader Willi if occurring in the paternal chromosome, or Angelman Syndrome if occurring in the maternal chromosome. Prader Willi Syndrome is caused by paternal deletion or maternal uniparental disomy of chromosome 15 and it is commonly characterized by diminished fetal activity, obesity, hypotonia, intellectual disability, short stature etc. Angelman Syndrome is originated from maternal deletion or paternal uniparental disomy and is characterized by jerky movements, abnormal laugher, sleep disturbances and characteristic facial features.

      • The Igenomix Prader Willi and Angelman Syndrome Precision Panel can be used for an accurate and directed diagnosis ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved. 

      Indication

        • Hypotonia 
        • Feeding problems or failure to thrive 
        • Rapid weight gain  
        • Facial features: Narrow bifrontal diameter, almond-shaped palpebral fissures, narrow nasal bridge 
        • Hypogonadism 
        • Developmental delay and severe intellectual deficit 
        • Microcephaly 
        • Speech impairment 
        • Epilepsy 
        • Tongue protrusion 
        • Paroxysms of laughter 
        • Abnormal sleep patterns 
        • Hyperactivity 

      Clinical Utility

      The clinical utility of this panel is: 

      • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient. 
      • Early initiation of treatment involving a multidisciplinary team in the form management of hypotonia and poor feeding, evaluation of hypogonadism, management of obesity, monitoring for scoliosis and therapy 
      • Risk assessment and genetic counselling of asymptomatic family members according to the mode of inheritance.    
      • Improvement of delineation of genotype-phenotype correlation.  

      Genes & Diseases

      Methodology

      References

      See scientific referrals

      Margolis, S. S., Sell, G. L., Zbinden, M. A., & Bird, L. M. (2015). Angelman Syndrome. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 12(3), 641–650. https://doi.org/10.1007/s13311-015-0361-y 

      Butler, M. G., Miller, J. L., & Forster, J. L. (2019). Prader-Willi Syndrome – Clinical Genetics, Diagnosis and Treatment Approaches: An Update. Current pediatric reviews, 15(4), 207–244. https://doi.org/10.2174/1573396315666190716120925 

      Buiting, K., Williams, C., & Horsthemke, B. (2016). Angelman syndrome – insights into a rare neurogenetic disorder. Nature reviews. Neurology, 12(10), 584–593. https://doi.org/10.1038/nrneurol.2016.133 

      Bird L. M. (2014). Angelman syndrome: review of clinical and molecular aspects. The application of clinical genetics, 7, 93–104. https://doi.org/10.2147/TACG.S57386 

      Clayton-Smith, J., & Laan, L. (2003). Angelman syndrome: a review of the clinical and genetic aspects. Journal of medical genetics, 40(2), 87–95. https://doi.org/10.1136/jmg.40.2.87 

      Butler, M. G., Manzardo, A. M., & Forster, J. L. (2016). Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches. Current pediatric reviews, 12(2), 136–166. https://doi.org/10.2174/1573396312666151123115250 

      Bonello, D., Camilleri, F., & Calleja-Agius, J. (2017). Angelman Syndrome: Identification and Management. Neonatal network : NN, 36(3), 142–151. https://doi.org/10.1891/0730-0832.36.3.142 

      Madaan, M., & Mendez, M. D. (2021). Angelman Syndrome. In StatPearls. StatPearls Publishing. 

      descargar

      Detail description

      Download

      Request Information


      WE GUIDE YOU

      Fertility
      Inherited diseases prevention
      Healthy pregnancy

      To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

      OUR SERVICES

      Genetic solutions
      For patients
      How to send a sample?
      User manual

      ABOUT US

      About Igenomix
      Contact
      Quality
      Complaints
      Work with us

      FOLLOW IGENOMIX

        + 96 390 53 10
        Write us
      • Argentina
      • Brazil
      • Canada
      • Chile
      • Colombia
      • Europe
      • France
      • Germany
      • India
      • Italy
      • Japan
      • Korea
      • Mexico
      • Perú
      • Russia
      • Spain
      • Taiwan
      • The Middle East
      • Turkey
      • United Kingdom
      • United States
      • Vietnam
      Country/Region

      [2021] © Igenomix Privacy policy Quality policy Legal note Cookies policyNews and Press

      Request Information

















      • We guide you
        • Fertility
          • What to do if…
        • Prevent Inherited Diseases
          • Carrier Genetic Test
        • Worry-free Pregnancy
          • NACE
          • Prenatal Diagnostics
          • Newborn Health
      • Reproductive Health
        • Specialists
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • POC
          • SAT
          • Newborn Screening
        • Patients
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • SAT
          • POC
      • Diagnostics
      • About us
        • Igenomix Research
        • About Igenomix
        • Igenomix Worldwide
      • Academy
      • Blog
      • Country/Region
      • +34 96 390 53 10
      • Clinic Portal
      • Request Information

      We are using cookies to give you the best experience on our website.

      You can find out more about which cookies we are using or switch them off in settings.

      International
      Powered by  GDPR Cookie Compliance
      Privacy Overview

      This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

      Strictly Necessary Cookies

      Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

      If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

      3rd Party Cookies

      This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

      Keeping this cookie enabled helps us to improve our website.

      Please enable Strictly Necessary Cookies first so that we can save your preferences!

      Cookie Policy

      More information about our Cookie Policy